(Q36441993)

14 August 2017

1 reference

title

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials (English)

1 reference

amyotrophic lateral sclerosis

14 August 2017

1 reference

1 reference

Orla Hardiman

5

0 references

Pierre-Marie Preux

object named as

Pierre-Marie Preux

9

0 references

Ettore Beghi

1

object named as

Ettore Beghi

1 reference

14 August 2017

2

Adriano Chiò

1 reference

14 August 2017

15

Jan H Veldink

1 reference

14 August 2017

6

Giancarlo Logroscino

1 reference

14 August 2017

13

Bryan J Traynor

1 reference

ORCID Public Data File 2021

14 August 2017

1 reference

author name string

Philippe Couratier

3

1 reference

14 August 2017

Jesùs Esteban

4

1 reference

14 August 2017

Andrea Millul

7

1 reference

14 August 2017

Douglas Mitchell

8

1 reference

14 August 2017

Elisabetta Pupillo

10

1 reference

14 August 2017

Zorica Stevic

11

1 reference

14 August 2017

Robert Swingler

12

1 reference

14 August 2017

Leonard H Van den Berg

14

1 reference

14 August 2017

Stefano Zoccolella

16

1 reference

14 August 2017

Eurals Consortium

17

1 reference

14 August 2017

11 August 2010

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

14 August 2017

1 reference

14 August 2017

12

1 reference

14 August 2017

1

1 reference

14 August 2017

1-10

1 reference

Biomarkers in amyotrophic lateral sclerosis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

The epidemiology of ALS and the role of population-based registries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Neuroprotective agents for clinical trials in ALS: a systematic assessment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Capture-recapture methods in epidemiology: methods and limitations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

30 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Incidence of ALS in Lombardy, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990-1991) veterans using capture-recapture methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Can we eliminate placebo in ALS clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Incidence of ALS in Italy: evidence for a uniform frequency in Western countries.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3513399

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

21 September 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482968.2010.502940

Branched-chain amino acids and amyotrophic lateral sclerosis: a treatment failure? The Italian ALS Study Group

21 January 2018

1 reference

12 December 2020

Incidence of amyotrophic lateral sclerosis in three counties in western Washington state

1 reference

12 December 2020

127th ENMC International Workshop: implementation of a European registry of ALS. Naarden, The Netherlands, 8-10 October 2004

1 reference

12 December 2020

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

12 December 2020

The administration of guanidine in amyotrophic lateral sclerosis

1 reference

12 December 2020

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

12 December 2020

A rating scale for amyotrophic lateral sclerosis: description and preliminary experience

1 reference

12 December 2020

Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988

1 reference

12 December 2020

10.3109/17482968.2010.502940

Identifiers

DOI

1 reference

release_zmbgsqzpvvbxddugosbe7jlsv4

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zmbgsqzpvvbxddugosbe7jlsv4

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

1 reference